US Surgical has new products line-up on show
This article was originally published in Clinica
Executive Summary
Chairman Leon Hirsch says US Surgical is no longer losing market share to Ethicon, but is holding its place in both the suture and MIS market. The company displayed a much wider range of products at this year's American College of Surgeons annual clinical congress than in previous years including a significant number of new and improved items. Work in the pipeline includes such diverse products as xenograft organs and minimally invasive heart surgery equipment.
You may also be interested in...
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.
Pharma Can Pursue Claims Against Providers For 340B Duplicate Discounts In Medicaid Managed Care, HRSA Says
The statement, which is part of a final rule on the 340B administrative dispute resolution process, could facilitate manufacturer efforts to seek repayments from hospitals in such cases.